USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CALCYTE THERAPEUTICS, INC.
Address:
5082 GREENWILLOW LN
SAN DIEGO, CA 92130
Phone:
N/A
URL:
N/A
EIN:
127047728
DUNS:
831270843
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $453,263.00 2

Award List:

Validation and development of specific small molecule inhibitors of HTRA1 for tre

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$249,411.00
Agency:
HHS
Principal Investigator:
Shuyuan Yao
Abstract:
DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the most common cause of visual impairment of the elderly in developed countries. Despite its prevalence with the aging population, its etiology and pathogenesis are poorly unde rstood and the treatment options are… More

iPS cell enabled therapy for geographic atrophy

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$203,852.00
Agency:
HHS
Principal Investigator:
Shuyuan Yao
Abstract:
DESCRIPTION (provided by applicant): One specific focus and expertise of CalCyte Therapeutics Inc. is to develop and apply small molecule driven (i.e. chemically defined), stem cell based therapy to treat geographic atrophy (GA) from age-related macular de generation (AMD). AMD affects 30-50 million… More